By Kathryn Hardison

General Electric Co.'s healthcare business has received clearance from the Food and Drug Administration for its AIR Recon DL for 3D and Propeller imaging sequences.

GE Healthcare said Thursday that the new applications will create better MRI image quality, shorter scan times and an enhanced patient experience.

The company said that the expanded compatibility from 2D to 3D imaging sequences will allow physicians to quickly diagnose patients with improved signal-to-noise ratio and sharpness. The compatibility with Propeller, a motion-insensitive imaging sequence, will also improve imaging for patients who have difficulty remaining still for the duration of the scan, the company said.

GE Healthcare is a $17.7 billion business under GE focused on medical technology, pharmaceutical diagnostics and digital solutions.

Write to Kathryn Hardison at kathryn.hardison@wsj.com

(END) Dow Jones Newswires

September 29, 2022 11:37 ET (15:37 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
GE Aerospace (NYSE:GE)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas GE Aerospace.
GE Aerospace (NYSE:GE)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas GE Aerospace.